J&J Medical Connect
Oncology
Oncology

Utility and Sensitivity of WETT-SA53 to Measure Dysgeusia Associated With Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma: Preliminary Data From the TALISMAN Study